(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDEXEL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MEDEXEL

ST13

US500000075866387

Class

10

Filing

75866387

Registration

2618618

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

03/23/2023

Trademark type

Word

Nice classes

10

Filing date

12/07/1999

Registration date

09/10/2002

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/23/2023

Last transaction

03/23/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

02/13/2000

First use in commerce

01/15/2001

Drawing code

1

Owner type

03

Owner location

Redondo Beach, CA, US

Examiner

DALIER, JOHN DAVID

Law office

L50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

EXELINT INTERNATIONAL CO.
EXELINT INTERNATIONAL CO.

Representatives

C. Wook Pak, Esq. Cislo & Thomas LLP

Technical classification

Nice Classes

Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 10

Disposable syringescatheter needles and blood drawing apparatus

Publications

History of USPTO decisions and trademark events.

40 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/23/2023

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

03/23/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/23/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/23/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

09/12/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

09/10/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/20/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/20/2021

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

07/20/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/20/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/20/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/20/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

11/05/2013

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

11/05/2013

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/05/2013

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/26/2011

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/26/2011

E89R

TEAS SECTION 8 & 9 RECEIVED

09/22/2011

CFIT

CASE FILE IN TICRS

01/16/2008

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/10/2007

PLGL

ASSIGNED TO PARALEGAL

12/10/2007

E815

TEAS SECTION 8 & 15 RECEIVED

09/19/2007

R.PR

REGISTERED-PRINCIPAL REGISTER

09/10/2002

MAIL

PAPER RECEIVED

07/15/2002

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/25/2002

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/19/2002

CNRT

NON-FINAL ACTION MAILED

03/19/2002

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/06/2002

DOCK

ASSIGNED TO EXAMINER

01/25/2002

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/23/2002

IUAF

USE AMENDMENT FILED

01/04/2002

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

12/04/2001

PUBO

PUBLISHED FOR OPPOSITION

09/11/2001

NPUB

NOTICE OF PUBLICATION

08/22/2001

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/11/2001

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/10/2001

CNFR

FINAL REFUSAL MAILED

03/07/2001

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/07/2000

CNRT

NON-FINAL ACTION MAILED

05/05/2000

DOCK

ASSIGNED TO EXAMINER

05/03/2000

Continuous trademark protection

Get notified about every new filing that threatens MEDEXEL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.